U.S. Genetic Testing Market to Reach USD 16.92 Billion and Europe USD 18.78 Billion by 2035, Driven by NGS, Liquid Biopsy and Personalized Medicine U.S. Genetic Testing Market to Reach USD 16.92 Billion and Europe USD 18.78 Billion by 2035, Driven by NGS, Liquid Biopsy and Personalized Medicine
Opportunities center on sterile, high-barrier and smart packaging for biologics and injectables; automated production; compliant, traceable formats; and localized manufacturing, diversified sourcing and resilient supply chains. Opportunities center on sterile, high-barrier and smart packaging for biologics and injectables; automated production; compliant, traceable formats; and localized manufacturing, diversified sourcing and resilient supply chains.